Nine biotech companies are set to make significant advances in 2024. Aiolos Bio, focusing on treatments for respiratory and inflammatory diseases, plans its phase 2 clinical trial. Capstan Therapeutics is developing treatments with precise cell engineering. Carisma Therapeutics is developing cancer treatments. Cellarity uses AI for drug discovery. Kriya Therapeutics is backed by $600 million for gene therapy development. Maze Therapeutics uses genetics to develop precision medicines. Quotient Therapeutics uses advanced sequencing technology. ReNAgade Therapeutics, with $300 million in funding, develops RNA medicines. OrsoBio focuses on therapies for severe metabolic disorders.
These were the badly handled data breaches of 2024
TechCrunch has summarized major data breaches from 2021. Key examples include: genetic testing giant 23andMe losing data for close to 7 million customers and blaming
